Hemodynamic and vascular responses to antihypertensive treatment with adrenergic blocking agents: A review
dc.contributor.author | Sannerstedt, Rune | en_US |
dc.contributor.author | Conway, James | en_US |
dc.date.accessioned | 2006-04-17T15:14:03Z | |
dc.date.available | 2006-04-17T15:14:03Z | |
dc.date.issued | 1970-01 | en_US |
dc.identifier.citation | Sannerstedt, Rune, Conway, James (1970/01)."Hemodynamic and vascular responses to antihypertensive treatment with adrenergic blocking agents: A review." American Heart Journal 79(1): 122-127. <http://hdl.handle.net/2027.42/32838> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6W9H-4BTH930-1F5/2/ea831848da1e2b9e8bf7b21b024b5e14 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/32838 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=4903136&dopt=citation | en_US |
dc.description.abstract | While the pharmacological effects of the three agents discussed (reserpine derivatives, guanethidine, and methyldopa) appear to depend upon interference with sympathetic nervous activity, they differ in their effects in man.After acute administration, there is a fall in blood pressure with each agent, but with reserpine and methyldopa, cardiac output is little affected. With methyldopa, the renal resistance appears to fall. Guanethidine produces a sharp fall in the cardiac output and renal blood flow.After treatment for a few days with these agents, the differences in their actions are less apparent, and from the very limited information available on long-term therapy, each of these agents achieves its hypotensive effect without reduction in cardiac output. The renal blood flow remains at control levels with reserpine and methyldopa but is still somewhat reduced with guanethidine.From the practical point of view, therefore, the decision to use one or another of these agents should rest upon differences in their clinical effectiveness and side effects. There is an urgent need for information on the changes in the action of these drugs during long-term therapy. These changes could be caused by the drugs' pharmacological effects or by physiological adaptations within the patient. | en_US |
dc.format.extent | 597310 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Hemodynamic and vascular responses to antihypertensive treatment with adrenergic blocking agents: A review | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Clinical Physiology Unit, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Mich. 48104, USA. | en_US |
dc.contributor.affiliationum | Clinical Physiology Unit, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Mich. 48104, USA. | en_US |
dc.identifier.pmid | 4903136 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/32838/1/0000214.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0002-8703(70)90402-3 | en_US |
dc.identifier.source | American Heart Journal | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.